Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (11): 1219-1224.

Previous Articles     Next Articles

Pharmacokinetics of 9-nitro-camptothecin in Beagle dogs

YAN Jing-chao, MA Yue-ming, WANG Tian-ming, ZHANG Fang1, YAN Dong-ming, Tan Bo, XIE Hua, Zhang Xiao-chen, YU Tie-liu2   

  1. PharmacokineticLaboratory,1Institute of Chinese Materia Medica,Shanghai University of TCM,Shanghai 201203,China;
    2Chengdu Qie Nai ErBio-technology Co.,Ltd.Chengdu 610015,Sichuan,China
  • Received:2005-08-10 Revised:2005-08-10 Online:2005-11-26 Published:2020-11-12

Abstract: AIM: To study the pharmacokinetics of 9-nitro-camptothecin(9-NC)in dogs.METHODS: Each Beagle dog was given a single dose of 9-NC by iv orig administration.The concentrations of 9-NC in plasma were detected by HPLC and HPLC-MS.Pharmacokinetic parameters were determined from the plasma concentra-tion-time data with the 3P97 software package.The rela-tionships betweenAUC,C max orke and dose were evaluat-ed by linearregression.RESULTS: Afteriv administra-tion of 9-NC at the dose of 0.5,1,and 2 mg·kg-1,the t1/2values of 9-NC were 2.2±2.2,1.8±1.7 and 0.8±0.6 h,respectively,and AUC0-twere 105±71,272±81 and 396±93 ng·h·ml-1,respectively.Afterig ad-ministration of 9-NC at the dose of 1,2,and 4 mg·kg-1,9-NC was rapidly absorbed,reaching Cmaxof 9.3±8.2,42±36 and 64±6 ng·ml-1at Tmaxof 0.3±0.1,0.2±0.1,0.4±0.1 h,respectively,the t1/2values of 9-NC were 1.9±1.3,1.0±0.6 and 2.8±1.5 h,respective-ly,and AUC0-twere 8.9±7.2,16±12 and 60±26ng·h·ml-1,respectively.The values of t1/2and ke of 9-NC were independent of dose(P>0.05).The absolute oral bioavailability of 9-NC was less than 6%.CONCLUSION: Afteriv orig administration of 9-NC,the time course of plasma concentration in dogs complieswith a two-compartment model.The kinetic process of 9-NC in dogs is linearin the range of the experimental dosage.9-NC is absorbed rapidly afterig administration and the oral bioavailability is poor.

Key words: 9-nitro-camptothecin, pharmacokinet-ics, dogs, HPLC, HPLC-MS

CLC Number: